https://www.hcplive.com/view/despite-improved-screening-and-rates-of-dyslipidemia-prescribing-not-yet-at-optimal-levels
An analysis of NHANES data from 1999-2018 details the progress made with regard to cholesterol management on a population level but also provides insight into areas where room for improvement still exists.
Create an account or login to join the discussion